Myeloproliferative disorder therapy: ass
β
Dermot Kenny
π
Article
π
2009
π
John Wiley and Sons
π
English
β 64 KB
## Abstract Although some cardiac effects, such as palpitations and tachycardia, occur commonly in healthy people, they have also been shown to be associated with agents used to treat the myeloproliferative disorders. Various strategies exist to prevent and manage cardiac effects and minimise their